cgp 36742 has been researched along with (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride in 1 studies
| Studies (cgp 36742) | Trials (cgp 36742) | Recent Studies (post-2010) (cgp 36742) | Studies ((4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride) | Trials ((4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride) | Recent Studies (post-2010) ((4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride) |
|---|---|---|---|---|---|
| 63 | 3 | 2 | 285 | 0 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerber, D; Giocomo, LM; Hasselmo, ME; Huang, SY; Kremin, T; Tonegawa, S | 1 |
1 other study(ies) available for cgp 36742 and (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
| Article | Year |
|---|---|
Muscarinic suppression in stratum radiatum of CA1 shows dependence on presynaptic M1 receptors and is not dependent on effects at GABA(B) receptors.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Dose-Response Relationship, Drug; Evoked Potentials; GABA Antagonists; Hippocampus; In Vitro Techniques; Interneurons; Mice; Mice, Knockout; Muscarinic Agonists; Nerve Net; Organophosphorus Compounds; Receptor, Muscarinic M1; Receptors, GABA-B; Receptors, Presynaptic; Synaptic Transmission | 2006 |